Kabiru A Y, Gbodi A Timothy A, Bello U M, Makun Hussaini Anthony, Amah D J, Ogbadoyi E O
Trypanosomiasis and Malaria Research Unit, Department of Biochemistry, Federal University of Technology, Minna, Nigeria.
Pak J Biol Sci. 2013 Jun 1;16(11):510-6. doi: 10.3923/pjbs.2013.510.516.
This study was designed to evaluate the changes in some hematological parameters of P-berghei-infected mice treated with aqueous extract of Phyllantus amarus, a plant that is used traditionally to treat malaria patients in some Nigerian communities. The aqueous extract of the leaves at 200, 400 and 600 mg kg(-1) body weight/day dose levels were used to treat the test groups immediately after infection for the suppressive test and 72 hours post infection for the curative test while a standard antimalarial drug, Artesunate, at a dose of 50 mg kg(-1) body weight was administered on the positive control group. The negative control group was left untreated. The level of parasitemia, variation in weight, Percentage Packed Cell Volume (% PCV), erythrocytes (RBC) and leukocytes (WBC) counts in the different groups were monitored throughout the period of study. The crude extract was screened for its phytochemical composition. The crude extract at 200, 400 and 600 mg kg(-1) body weight/day suppressed parasitemia by 54.67, 61.25 and 61.24% after treating for four days in the suppressive test as against 72.32% for the standard drug while the level of parasitemia was reduced by 64.35, 66.71 and 67.13%, respectively after treating for five days in the curative test as against 71.87% for the standard drug. The variations in the values of Percentage Packed Cell Volume (% PCV), weight, leukocyte and erythrocyte counts for treated groups before and after treatment was not significant (p < 0.05). Alkaloids, flavonoids, tannins, glycosides, saponin, carbohydrate and phenols were found to be present in the crude extract. The findings of this study show that the use of Phyllantus amarus as antimalaria regimen by local medical practitioners does not adversely affect the weight and the haematological parameters determined.
本研究旨在评估用苦味叶下珠水提取物治疗感染伯氏疟原虫小鼠后某些血液学参数的变化。苦味叶下珠是一种在尼日利亚一些社区传统上用于治疗疟疾患者的植物。在感染后立即使用200、400和600毫克/千克体重/天剂量水平的叶水提取物治疗试验组进行抑制试验,并在感染后72小时进行治疗试验,而阳性对照组则给予剂量为50毫克/千克体重的标准抗疟药物青蒿琥酯。阴性对照组不进行治疗。在整个研究期间监测不同组的寄生虫血症水平、体重变化、红细胞压积百分比(%PCV)、红细胞(RBC)和白细胞(WBC)计数。对粗提取物进行了植物化学成分筛选。在抑制试验中,200、400和600毫克/千克体重/天的粗提取物在治疗四天后分别抑制寄生虫血症54.67%、61.25%和61.24%,而标准药物为72.32%;在治疗试验中,治疗五天后寄生虫血症水平分别降低64.35%、66.71%和67.13%,而标准药物为71.87%。治疗组治疗前后红细胞压积百分比(%PCV)、体重、白细胞和红细胞计数的值变化不显著(p<0.05)。发现粗提取物中存在生物碱、黄酮类化合物、单宁、糖苷、皂苷、碳水化合物和酚类。本研究结果表明,当地医生将苦味叶下珠用作抗疟方案不会对所测定的体重和血液学参数产生不利影响。